Tag:
Bradley Pharma
Latest Headlines
Latest Headlines
Sepracor owes Medicaid, buys drug rights
Uh-oh, Sepracor says. The maker of the Lunesta sleeping pill estimates that it owes Medicaid between $80 million and $100 million, because it charged too much for its products from 2002 to 2007. The
SPOTLIGHT: Nycomed to acquire Bradley Pharma
Nycomed is building up its dermatology operations with its deal to buy Bradley Pharmaceuticals. Executives involved in the merger say that the acquisition--at $20 a share--will position Nycomed to
ALSO NOTED: Bayer expands production; India may replace drug agency; Ranbaxy in Bradley hunt;
> Bayer plans to more than double its production of over-the-counter meds in Indonesia, to 2,000 tons annually from its current 700 tons. The company acquired its West Java plant from Roche and
Rumor Mill: Dr. Reddy bids for Bradley
Leading Indian generics maker Dr. Reddy's Laboratories is rumored to have submitted a bid for U.S.-based Bradley Pharma. A leading Indian television channel is quoting anonymous sources about the
ALSO NOTED: Novartis licenses MedImmune vaccine IP; Rumor Mill: Dr. Reddy bids for Bradley; and much more...
> Rumor Mill:Â Generic drugmaker Dr. Reddy's Laboratories is said to have submitted a bid for U.S.-based Bradley Pharma.
